Gilead Sciences GILD
NASDAQ GILD
$157.19 +3.62 (+2.36%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Short-Term Debt issuances (2012)

Updated

Gilead Sciences (GILD) posted Short-Term Debt issuances of $148.96 million for Q3 2012.

Analysis

Gilead Sciences (GILD) Short-Term Debt issuances (2012) Analysis & Trends

For the trailing twelve months through Sep 30, 2012, Short-Term Debt issuances at Gilead Sciences was $1.15 billion; for FY2010, it came in at $500 million, up 25.0% from FY2009.

  • In prior years, Gilead Sciences' Short-Term Debt issuances was $400 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.28 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 135.25 Bn 107.26 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 148.96 Mn
Mar 31, 2012 997.89 Mn
API Access

Gilead Sciences Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=GILD&period=max&api_key=YOUR_API_KEY